Related references
Note: Only part of the references are listed.Local co-delivery of rhBMP-2 and cathepsin K inhibitor L006235 in poly(d,l-lactide-co-glycolide) nanospheres
Nicole Y. C. Yu et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS (2017)
Repeated oral administration of a cathepsin K inhibitor significantly suppresses bone resorption in exercising horses with evidence of increased bone formation and maintained bone turnover
H. Hussein et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2017)
Antiresorptive effect of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis
Makoto Tanaka et al.
BMC MUSCULOSKELETAL DISORDERS (2017)
Identification of mouse cathepsin K structural elements that regulate the potency of odanacatib
Simon Law et al.
BIOCHEMICAL JOURNAL (2017)
A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin K
Preety Panwar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Cathepsin K Inhibition: A New Mechanism for the Treatment of Osteoporosis
Le T. Duong et al.
CALCIFIED TISSUE INTERNATIONAL (2016)
New horizons in osteoporosis therapies
Torben Harslof et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Linkers Having a Crucial Role in Antibody-Drug Conjugates
Jun Lu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Discovery of a New Class of Cathepsin K Inhibitors in Rhizoma Drynariae as Potential Candidates for the Treatment of Osteoporosis
Zuo-Cheng Qiu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Structural requirements for the collagenase and elastase activity of cathepsin K and its selective inhibition by an exosite inhibitor
Vidhu Sharma et al.
BIOCHEMICAL JOURNAL (2015)
Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors
Jure Borisek et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Effect of ONO-5334 on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis: 2-Year Results From the OCEAN Study
Richard Eastell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Salvia miltiorrhiza: An ancient Chinese herbal medicine as a source for anti-osteoporotic drugs
Yubo Guo et al.
JOURNAL OF ETHNOPHARMACOLOGY (2014)
Chinese herbal medicine for bone health
Emmanuel Mukwaya et al.
PHARMACEUTICAL BIOLOGY (2014)
A novel allosteric mechanism in the cysteine peptidase cathepsin K discovered by computational methods
Marko Novinec et al.
NATURE COMMUNICATIONS (2014)
Effects of pharmacological inhibition of cathepsin K on fracture repair in mice
Do Y. Soung et al.
BONE (2013)
Cathepsin K Inhibitors: A Novel Target but Promising Approach in the Treatment of Osteoporosis
Asadul Mazid Helali et al.
CURRENT DRUG TARGETS (2013)
An inhibitor of cathepsin K, icariin suppresses cartilage and bone degradation in mice of collagen-induced arthritis
Peijiao Sun et al.
PHYTOMEDICINE (2013)
Highly selective aza-nitrile inhibitors for cathepsin K, structural optimization and molecular modeling
Xiao-Yu Yuan et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2013)
Odanacatib in the Treatment of Postmenopausal Women With Low Bone Mineral Density: Five Years of Continued Therapy in a Phase 2 Study
Bente Langdahl et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
(1R,2R)-N-(1-Cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b)indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): A Potent and Highly Selective Cathepsin K Inhibitor for the Treatment of Osteoarthritis
Alexander G. Dossetter et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Osteogenic effect of Drynariae rhizoma extracts and Naringin on MC3T3-E1 cells and an induced rat alveolar bone resorption model
Li-li Chen et al.
ARCHIVES OF ORAL BIOLOGY (2011)
Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism
Yasuo Ochi et al.
BONE (2011)
Inhibitors of cathepsin K: a patent review (2004-2010)
Jac Wijkmans et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Cathepsin K Inhibitors Prevent Bone Loss in Estrogen-Deficient Rabbits
Brenda L. Pennypacker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Odanacatib in the Treatment of Postmenopausal Women With Low Bone Mineral Density: Three-Year Continued Therapy and Resolution of Effect
John A. Eisman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE2 synthesis
Tsai-Pei Hsieh et al.
PHYTOMEDICINE (2011)
6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors
Jiaqiang Cai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
The discovery of MK-0674, an orally bioavailable cathepsin K inhibitor
Elise Isabel et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors
Zoran Rankovic et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Emerging Targets in Osteoporosis Disease Modification
John G. Allen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Investigation of ketone warheads as alternatives to the nitrile for preparation of potent and selective cathepsin K inhibitors
Michael J. Boyd et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I Studies
S. A. Stoch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Cathepsin K inhibitors prevent matrix-derived growth factor degradation by human osteoclasts
Karen Fuller et al.
BONE (2008)
Effect of cathepsin K inhibitors on bone resorption
Naoki Teno et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Identification of a Nonbasic, Nitrile-Containing Cathepsin K Inhibitor (MK-1256) that is Efficacious in a Monkey Model of Osteoporosis
Joel Robichaud et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Cathepsin K-dependent Toll-like receptor 9 signaling revealed in experimental arthritis
Masataka Asagiri et al.
SCIENCE (2008)
Cathepsin K inhibitors: A novel target for osteoporosis therapy
S. A. Stoch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Novel scaffold for cathepsin K inhibitors
Naoki Teno et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
β-substituted cyclohexanecarboxamide cathepsin K inhibitors:: Modification of the 1,2-disubstituted aromatic core
Joel Robichaud et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
2-cyano-pyrimidines: A new chemotype for inhibitors of the cysteine protease cathepsin K
Eva Altmann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys
S. Kumar et al.
BONE (2007)
Potent and selective cathepsin K inhibitors
Tsuyoshi Shinozuka et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Arylamine based cathepsin K inhibitors: Investigating P3 heterocyclic substituents
Tsuyoshi Shinozuka et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Fracture incidence and characterization in patients on osteoporosis treatment: The ICARO study
Silvano Adami et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Dipeptide nitrile inhibitors of cathepsin K
E Altmann et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Identification of a potent and selective non-basic cathepsin K inhibitor
CS Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
4-aminophenoxyacetic acids as a novel class of reversible cathepsin K inhibitors
T Shinozuka et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Structure activity relationships of 5-, 6-, and 7-methyl -substituted azepan-3-one cathepsin K inhibitors
DS Yamashita et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
β-substituted cyclohexanecarboxamide:: A nonpeptidic framework for the design of potent inhibitors of cathepsin K
SN Crane et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Non-covalent cathepsin K inhibitors for the treatment of osteoporosis
TS Kim et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K
JT Palmer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity
JP Falgueyret et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K
WC Black et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
The role of cathepsins in osteoporosis and arthritis:: Rationale for the design of new therapeutics
Y Yasuda et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
3,4-disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity
EL Setti et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Effects of Drynariae rhizoma on the proliferation of human bone cells and the immunomodulatory activity
JC Jeong et al.
PHARMACOLOGICAL RESEARCH (2005)
Rational design of potent and selective NH-linked aryl/heteroaryl cathepsin K inhibitors
J Robichaud et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells
JP Falgueyret et al.
ANALYTICAL BIOCHEMISTRY (2004)
Exploration of the P2-P3SAR of aldehyde cathepsin K inhibitors
EE Boros et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Cathepsin K inhibitor-polymer conjugates:: potential drugs for the treatment of osteoporosis and rheumatoid arthritis
D Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Bicyclic peptidomimetic tetrahydrofuro[3,2-b]pyrrol-3-one and hexahydrofuro[3,2-b]pyridine-3-one based scaffolds:: synthesis and cysteinyl proteinase inhibition
M Quibell et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Pivotal role of cathepsin K in lung fibrosis
F Bühling et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Synthesis, structure and conformation of partially-modified retro- and retro-inverso ψ[NHCH(CF3)]Gly peptides
A Volonterio et al.
CHEMISTRY-A EUROPEAN JOURNAL (2003)
A novel class of nonpeptidic biaryl inhibitors of human cathepsin K
J Robichaud et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Arylaminoethyl amides as inhibitors of the cysteine protease cathepsin K -: Investigating P1′ substituents
E Altmann et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
3,4-disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P2 elements for selectivity
EL Setti et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Design and synthesis of dipeptide nitriles as reversible and potent cathepsin S inhibitors
YD Ward et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Human and parasitic papain-like cysteine proteases:: Their role in physiology and pathology and recent developments in inhibitor design
F Lecaille et al.
CHEMICAL REVIEWS (2002)
The effect of Gu-Sui-Bu (Drynaria fortunei J. Sm) on bone cell activities
JS Sun et al.
BIOMATERIALS (2002)
Inhibition of cathepsin K with lysosomotropic macromolecular inhibitors
D Wang et al.
BIOCHEMISTRY (2002)
Arylaminoethyl amides as novel non-covalent cathepsin K inhibitors
E Altmann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
A new dimeric dihydrochalcone and a new prenylated flavone from the bud covers of Artocarpus altilis:: Potent inhibitors of cathepsin K
AD Patil et al.
JOURNAL OF NATURAL PRODUCTS (2002)
Haploscleridamine, a novel tryptamine-derived alkaloid from a sponge of the order Haploselerida: An inhibitor of cathepsin K
AD Patil et al.
JOURNAL OF NATURAL PRODUCTS (2002)
Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design
PD Greenspan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Azepanone-based inhibitors of human and rat cathepsin K
RW Marquis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Cyclic ketone inhibitors of the cysteine protease cathepsin K
RW Marquis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L
JP Falgueyret et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Cathepsin K and the design of inhibitors of cathepsin K
DS Yamashita et al.
CURRENT PHARMACEUTICAL DESIGN (2000)
Share Paper
